Neuropathology-based risk scoring for dementia diagnosis in the elderly

Journal of Alzheimer's Disease

Volumn 17, Issue 4, 2009, Pages 875-885

  Haneuse, Sebastien ^a,b   Larson, Eric ^a   Walker, Rod ^a   Montine, Thomas ^b   Sonnen, Joshua ^b  

^a CENTER FOR HEALTH STUDIES   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Alzheimer's disease; Autopsy; Dementia; Microinfarcts; Neuropathology; Prediction; Selection bias

Indexed keywords

AGED; ARTICLE; AUTOPSY; BRAIN INFARCTION; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VASCULAR AMYLOIDOSIS; AGE; AGING; ALZHEIMER DISEASE; BRAIN; CONFIDENCE INTERVAL; DEMENTIA, VASCULAR; PATHOLOGY; SEX DIFFERENCE; STATISTICAL BIAS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AUTOPSY; BIAS (EPIDEMIOLOGY); BRAIN; CONFIDENCE INTERVALS; DEMENTIA; DEMENTIA, VASCULAR; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; SEX FACTORS;

EID: 68949099364     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1105     Document Type: Article

References (35)

1. Hyman B, Trojanowski J (1997) Consensus recommendations for the postmortem diagnosis of Alzheimer's disease from The National Institute on Aging Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer's disease. Neurobiol Aging 18, S1-2.
2. Vinters HV (2000) Surgical pathologic findings of extratemporal-based intractable epilepsy. A study of 133 consecutive cases. Arch Pathol Lab Med 124, 1111-1112.
3. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC (2002) Subcortical ischaemic vascular dementia. Lancet Neurol 1, 426-436.
4. Kalaria RN, Kenny RA, Ballard CG, Perry R, Ince P,Polvikos-ki T (2004) Towards defining the neuropathological substrates of vascular dementia. J Neurol Sci 226, 75-80.
5. Petrovitch H, Ross GW, Steinhorn SC, Abbott RD, Markesbery W, Davis D, Nelson J, Hardman J, Masaki K, Vogt MR, Launer L,White LR (2005) ADlesions and infarcts in demented and non-demented Japanese-American men. Ann Neurol 57, 98-103.
6. White L, Small BJ, Petrovitch H, Ross GW, Masaki K, Abbott RD, Hardman J, Davis D, Nelson J, Markesbery W (2005) Recent clinical-pathologic research on the causes of dementia in late life: update from the Honolulu-Asia Aging Study. J Geriatr Psychiatry Neurol 18, 224-227.
7. Jellinger KA (2006) Clinicopathological analysis of dementia disorders in the elderly-an update. J Alzheimers Dis 9, 61-70.
8. Harding AJ, Halliday GM (1998) Simplified neuropatholog-ical diagnosis of dementia with Lewy bodies. Neuropathol Appl Neurobiol 24, 195-201.
9. White L, Petrovitch H, Hardman J, Nelson J, Davis DG, Ross GW, MasakiK,LaunerL,MarkesberyWR(2002) Cerebrovas-cular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann N Y Acad Sci 977, 9-23.
10. Sonnen JA, Larson EB, Crane PK, Haneuse S, Li G, Schellen-berg GD, Craft S, Leverenz JB, Montine TJ (2007) Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol 62, 406-413.
11. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 58, 1147-1155.
12. Cochran EJ, Schneider JA, Bennett DA, Mufson EJ(1998) Application of NIA/Reagan Institute working group criteria for diagnosis of Alzheimer's disease to members of the Religious Orders Study. J Neuropathol Exp Neurol 57, 508.
13. Davis DGM, Schmitt FAP, Wekstein DRP, Markesbery WRM (1999) Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol 58, 376-388.
14. McKee AC, Kowall NW, al RAe (2002) Topography of neu-rofibrillary tangles distinguishes aging from Alzheimer de-sease. J Neuropathol Exp Neurol 61, 488.
15. Jellinger KA (2003) Neuropathology of Alzheimer disease and clinical relevance. In Alzheimer's Disease and Related Disorders: Research Advances, Khalid Iqbal BW, ed. "Ana Aslan" International Academy of Aging, Bucharest, Romania, pp. 152-169.
16. Geddes JW, Tekirian TL, Soultanian NS, Ashford JW, Davis DG, Markesbery WR (1997) Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease. Neurobiol Aging 18, S99-105.
17. Gold G, Giannakopoulos P, Herrmann FR, Bouras C, Kovari E (2007) Identification of Alzheimer and vascular lesion thresholds for mixed dementia. Brain 130, 2830-2836.
18. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140, 566-572.
19. Zaccai J, Ince P, Brayne C (2006) Population-based neu-ropathological studies of dementia: design, methods and areas of investigation-a systematic review. BMC Neurol 6, 2.
20. Kukull WA, Higdon R, Bowen JD, McCormick WC, Teri L, Schellenberg GD, van Belle G, Jolley L, Larson EB (2002) Dementia and Alzheimer disease incidence: a prospective cohort study. Arch Neurol 59, 1737-1746.
21. Teng EL, HasegawaK, HommaA,ImaiY, LarsonE, Graves A, Sugimoto K,Yamaguchi T, Sasaki H, Chiu D,et al. (1994) The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6, 45-58; discussion 62.
22. APA (1994) Diagnostic and statistical manual of mental disorders, American Psychiatric Association, Washington, DC.
23. Larson EB, Kukull WA, Teri L, McCormick W, Pfanschmidt M, van Belle G, Sumi M (1990) University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging (Milano) 2, 404-408.
24. Hastie T, Tibshirani R, Friedman JH (2001) The elements of statistical learning: data mining, inference, and prediction, Springer, New York.
25. McIntosh MW, Pepe MS (2002) Combining several screening tests: optimality of the risk score. Biometrics 58, 657-664.
26. Harrell FE, Lee KL, Mark DB (1996) Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 15, 361-387.
27. Haneuse S, Schildcrout J, Crane P, Sonnen J, Breitner J, Larson E (2009) Adjustment for selection bias in observational studies with application to the analysis of autopsy data. Neuroepidemiology 32, 229-239.
28. Pepe MS (2003) The statistical evaluation of medical tests for classification and prediction, Oxford University Press, Oxford ; New York.
29. Efron B, Tibshirani R (1993) An introduction to bootstrap, Chapman and Hall, London.
30. Knopman DS, Parisi JE, Salviati A, Floriach-Robert M, Boeve BF, Ivnik RJ, Smith GE, Dickson DW, Johnson KA, Petersen LE, McDonald WC, Braak H, Petersen RC (2003) Neuropathology of cognitively normal elderly. J Neuropathol Exp Neurol 62, 1087-1095.
31. Bennett DA, Schneider JA, Bienias JL, Evans DA, Wilson RS (2005) Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 64, 834-841.
32. Brunnstrom H, Gustafson L, Passant U, Englund E (2009) Prevalence of dementia subtypes: A 30-year retrospective survey of neuropathological reports. Arch Gerontol Geriatr 49, 146-149.
33. Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH (1998) Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease. N Engl J Med 338, 506-511.
34. Tsuang D, Larson EB, Bowen J, McCormick W, Teri L, Nochlin D, Leverenz JB, Peskind ER, Lim A, Raskind MA, Thompson ML, Mirra SS, Gearing M, Schellenberg GD, Kukull W (1999) The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. Arch Neurol 56, 1489-1495.
35. Ashford JW, Atwood CS, Blass JP, Bowen RL, Finch CE, Iqbal K, Joseph JA, Perry G (2005) What is aging? What is its role in Alzheimer's disease? What can we do about it? J Alzheimers Dis 7, 247-253; discussion 255-262.